Recent Finacing
Recent Raise
Invirsa develops INV-102, a topical eye-drop small molecule that modulates DNA repair and innate immunity, in clinical development for dry eye and infectious keratoconjunctivitis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Invirsa.
